A new trading day began on Monday, with Lilly(Eli) & Co (NYSE: LLY) stock price up 2.90% from the previous day of trading, before settling in for the closing price of $785.41. LLY’s price has ranged from $624.68 to $972.53 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 11.42%. Meanwhile, its annual earnings per share averaged 105.60%. With a float of $850.64 million, this company’s outstanding shares have now reached $950.22 million.
Let’s determine the extent of company efficiency that accounts for 43000 employees. In terms of profitability, gross margin is 81.56%, operating margin of 35.33%, and the pretax margin is 24.84%.
Lilly(Eli) & Co (LLY) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – General Industry. The insider ownership of Lilly(Eli) & Co is 10.39%, while institutional ownership is 72.52%. The most recent insider transaction that took place on Nov 08 ’24, was worth 723,042. Before that another transaction happened on Nov 08 ’24, when Company’s SVP, Finance, & CAO sold 900 for $803.38, making the entire transaction worth $723,042. This insider now owns 5,480 shares in total.
Lilly(Eli) & Co (LLY) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 4.92 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 105.60% per share during the next fiscal year.
Lilly(Eli) & Co (NYSE: LLY) Trading Performance Indicators
Here are Lilly(Eli) & Co’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.97. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 18.77. Likewise, its price to free cash flow for the trailing twelve months is 548.08.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 9.14, a number that is poised to hit 5.28 in the next quarter and is forecasted to reach 22.51 in one year’s time.
Technical Analysis of Lilly(Eli) & Co (LLY)
Looking closely at Lilly(Eli) & Co (NYSE: LLY), its last 5-days average volume was 4.01 million, which is a drop from its year-to-date volume of 4.2 million. As of the previous 9 days, the stock’s Stochastic %D was 75.23%. Additionally, its Average True Range was 23.70.
During the past 100 days, Lilly(Eli) & Co’s (LLY) raw stochastic average was set at 37.47%, which indicates a significant decrease from 98.72% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 42.91% in the past 14 days, which was higher than the 31.00% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $778.85, while its 200-day Moving Average is $839.27. However, in the short run, Lilly(Eli) & Co’s stock first resistance to watch stands at $818.71. Second resistance stands at $829.25. The third major resistance level sits at $849.25. If the price goes on to break the first support level at $788.17, it is likely to go to the next support level at $768.17. Should the price break the second support level, the third support level stands at $757.63.
Lilly(Eli) & Co (NYSE: LLY) Key Stats
With a market capitalization of 767.21 billion, the company has a total of 949,316K Shares Outstanding. Currently, annual sales are 34,124 M while annual income is 5,240 M. The company’s previous quarter sales were 11,439 M while its latest quarter income was 970,300 K.
